Putting patients first: An inventive service delivering cancer treatment at home

Abstract

Aim: This study evaluated the patient experience of receiving subcutaneous chemotherapy at home via a unique †Cancer Treatment at Home' outreach service adapted by the UK Clatterbridge Cancer Centre NHS Foundation Trust. Patients & methods: The service involved using highly trained nurses to deliver cancer treatments to patients in their own homes. Patient outcomes were monitored over 12 months via the Systemic Anti-Cancer Therapy at Home (SACT) survey using handheld electronic devices. Results: Of the 56 participating cancer patients, 53 provided responses. Patients received subcutaneous trastuzumab, denosumab, pembrolizumab, fulvestrant and goserelin. Overall, 96% of respondents were †very satisfied' and 4% †satisfied' with the service. All respondents would recommend the service to others. Conclusion: The †Cancer Treatment at Home' service has improved the patient experience for cancer care and has been recognized nationally for its achievements.